Sun Pharma Advanced Research Company Ltd expects to launch its novel dry-powder inhaler in India in the second quarter of financial year 2012.The inhaler, delivering a drug combination that delivers equivalent efficacy at half the dose, has completed the third phase of clinical trials in India. Phase-3 clinical trials involve testing the drug on large sample size of patients for safety and efficacy.For the US, ‘pre-investigative new drug meetings' have been completed, and the investigative new drug filing is likely in financial year 2012.crackcrack
